| |
| |
|
| Insider
Information: |
Petteway Stephen R Jr |
| Relationship: |
Executive VP, R&D |
| City: |
Research Triangle Park |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Talecris Biotherapeutics Holding... |
TLCR |
Executive VP, R&D |
2011-06-01 |
0 |
2009-09-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2011-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(42,796) |
0 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2011-04-01 |
4 |
D |
$26.94 |
$112,609 |
D/D |
(4,180) |
42,796 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2011-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,778 |
46,976 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2011-02-01 |
4 |
AS |
$24.37 |
$609,210 |
D/D |
(25,000) |
40,198 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2011-02-01 |
4 |
OE |
$1.39 |
$27,800 |
D/D |
20,000 |
65,198 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2011-01-03 |
4 |
AS |
$23.06 |
$576,595 |
D/D |
(25,000) |
45,198 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2011-01-03 |
4 |
OE |
$1.39 |
$27,800 |
D/D |
20,000 |
70,198 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2010-12-01 |
4 |
AS |
$21.50 |
$537,500 |
D/D |
(25,000) |
50,198 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2010-12-01 |
4 |
OE |
$1.39 |
$27,800 |
D/D |
20,000 |
75,198 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2010-11-01 |
4 |
AS |
$24.37 |
$609,258 |
D/D |
(25,000) |
55,198 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2010-11-01 |
4 |
OE |
$1.39 |
$27,800 |
D/D |
20,000 |
80,198 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2010-10-01 |
4 |
AS |
$22.81 |
$570,150 |
D/D |
(25,000) |
60,198 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2010-10-01 |
4 |
OE |
$1.39 |
$27,800 |
D/D |
20,000 |
85,198 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2010-09-01 |
4 |
AS |
$21.99 |
$549,813 |
D/D |
(25,000) |
65,198 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2010-09-01 |
4 |
OE |
$1.39 |
$27,800 |
D/D |
20,000 |
90,198 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&D |
• – – |
2010-03-31 |
4 |
D |
$19.92 |
$211,869 |
D/D |
(10,636) |
70,198 |
0 |
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Executive VP, R&DOfficer |
• – – |
2009-09-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
71,624 |
|
- |
|
| TLCR |
Talecris Biotherapeutics ... |
Ex. VP, Research & Development |
• – – |
2009-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
9,210 |
80,834 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
